首頁 › 慢性阻塞性肺病 › 俄亥俄州 › Columbus
Columbus, OH 的 慢性阻塞性肺病 臨床試驗
8 項針對 慢性阻塞性肺病 的研究正在 Columbus（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
招募中3 期
- Research Site, Columbus
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
招募中
- Ohio State East Hospital, Columbus
- OSU Wexner Medical Center, Columbus
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
招募中2 期
- Remington-Davis Research, Columbus
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
招募中2 期
- Copd01 50003, Columbus
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
招募中3 期
- Research Site, Columbus
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
招募中
- Ohio State University Medical Center - Ohio State Lung Center, Columbus
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
招募中
- The Ohio State University, Columbus
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
招募中
- Ohio State University Wexner Medical Center, Columbus
其他城市的 慢性阻塞性肺病 試驗
- Philadelphia, PA23 項研究
- Miami, FL18 項研究
- Birmingham, AL17 項研究
- Boston, MA17 項研究
- Houston, TX15 項研究
- Orlando, FL15 項研究
- Baltimore, MD14 項研究
- Chicago, IL14 項研究
- Dallas, TX12 項研究
- Pittsburgh, PA12 項研究
- New York City, NY11 項研究
- Ann Arbor, MI10 項研究
Columbus 的其他研究
- 非小細胞肺癌56 項研究
- 乳癌39 項研究
- 卵巢癌39 項研究
- 癌症（所有類型）38 項研究
- 肺癌37 項研究
- 急性髓系白血病35 項研究
- 慢性淋巴性白血病28 項研究
- 轉移性癌症27 項研究
- 子宮內膜癌25 項研究
- 大腸直腸癌24 項研究
- 前列腺癌24 項研究
- 多發性骨髓瘤24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。